Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03414593Unknown
Randomised, single-blind trial of ropivacaine in postoperative pain, sponsored by Asan Medical Center. Primary endpoint: Analgesic duration of nerve block. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03414593.